MDXG News and Press, MiMedx Group Inc

Study adds to the Company’s growing body of evidence and expands the understanding of the regulatory capabilities of its DHACM and LHACM allografts on the fibrotic process Marks MIMEDX’s first publication in the 5 th most-cited journal in the world MARIET...

Rick Barry appointed Executive Chairman of the Board Remi Barbier resigns as President and CEO and from the Board of Directors Cassava initiates search for a new CEO AUSTIN, Texas, July 17, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) today announced that the Boa...

MARIETTA, Ga., July 17, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30, 2024 after the market close on Wednesday, July 3...

2024-07-02 14:15:08 ET More on MiMedx Group MiMedx Group, Inc. (MDXG) Q1 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on MiMedx Group Historical earnings data for MiMedx Group Financial information for MiMedx Group Read the full...

2024-07-02 07:00:07 ET Ross Osborn from Cantor Fitzgerald issued a price target of $11.00 for MDXG on 2024-07-02 06:15:00. The adjusted price target was set to $11.00. At the time of the announcement, MDXG was trading at $6.7. The overall price target consensus is at $10...

2024-06-26 16:07:23 ET More on MiMedx Group Seeking Alpha’s Quant Rating on MiMedx Group Historical earnings data for MiMedx Group Financial information for MiMedx Group Read the full article on Seeking Alpha For further details see: MiMedx...

MARIETTA, Ga., June 26, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the appointment of Kim Moller to Chief Commercial Officer. Ms. Moller has been serving as the Company’s Senior Vice President, Sales si...

2024-06-13 04:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

(NewsDirect) Regenerative medicine is revolutionizing healthcare. It encompasses a range of cutting-edge therapies aimed at repairing or replacing damaged tissues and organs, offering tangible solutions rather than mere symptom management. With a global market projected to surge from USD 29.4...

2024-04-30 21:33:08 ET MiMedx Group, Inc. (MDXG) Q1 2024 Earnings Conference Call April 30, 2024, 04:30 PM ET Company Participants Matt Notarianni - Head of Investor Relations Joe Capper - Chief Executive Officer Doug Rice - Chief Financial Officer Conferen...